Prima BioMed Commences Randomised Phase IIb Clinical Trial for IMP321 in Breast Cancer

Friday, January 20, 2017 1 min read

Key Takeaway: Prima BioMed Commences Randomised Phase IIb Clinical Trial for IMP321 in Breast Cancer

Full Press Release Details

Prima BioMed Commences Randomised Phase IIb Clinical Trial for IMP321 in Breast Cancer.